Form D · Other Health Care
Biopharmgen Holdings, Inc.
La Verne, CA · CIK 0001505483
Offering snapshot reported Nov 16, 2010 · SEC filing
- Reported sold
- $115K Offering amount: $1M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $2.5K Reported outside-investor minimum
- First sale
- Jun 4, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 16, 2010 | Initial | $115,000 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-150550
Source: Form D, filed Nov 16, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michelle Lee | Director, Executive |
| Hui Qiong (Sophia) Li | Director |
| Jackson Wen | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1871 Wright Avenue
La Verne, CA, 91750
La Verne, CA, 91750